MiR-122 can increase the phosphorylation of protein kinase B (Akt) by reducing the expression of protocadherin 20 (PCDH20), which in turn leads to an increase in mTOR activity and ultimately causes the resistance of HCC cells to 5-FU[65]. Here, MTOR is linked to hepatocellular carcinoma.